Dolutegravir Sodium - ≥99% , Human immunodeficiency virus type 1 integrase inhibitor, CAS No.1051375-19-9, Human immunodeficiency virus type 1 integrase inhibitor

CAS: 1051375-19-9 Cat. No.: D275163 Summenformel: C20H18F2N3NaO5 Molekulargewicht: 441.36 EG-Nummer: 812-620-6
Zu bestellen verfügbar
QUALITÄT & REINHEIT ≥99%
Synonyms
DOLUTEGRAVIR SODIUM SALT [MI]|Dolutegravir (sodium)|Dolutegravir sodium salt|Dolutegravir sodium [USAN]|TIVICAY PD|Tivicay (TN)|SODIUM (4R,12AS)-9-(((2,4-DIFLUOROPHENYL)METHYL)CARBAMOYL)-4-METHYL-6,8-DIOXO-3,4,6,8,12,12A-HEXAHYDRO-2H-PYRIDO(1',2':4,5)PYRAZINO(2,1-B)(1,3)OXAZIN-7-OLATE|Sodium (4R,12aS)-9-((2,4-difluorobenzyl)carbamoyl)-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazin-7-olate|GSK1349572A|DOLUTEGRAVIR SODIUM|DOLUTEGRAVIR SODIUM [ORANGE BOOK]|Dovato|DOLUTEGRAVIR SODIUM [JAN]|N,N',N''-Triethylenephosphoramide|TRICHLORO-ACETIC ACID,NITRILE|MYRISTIC ACID (USP-RS)|Sodium (4R,12aS)-9-((2,4-difluorobenzyl)carbamoyl)-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazin-7-olate;Sodium (4R,12aS)-9-((2,4-difluorobenzyl)carbamoyl)-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyrido[|2H-PYRIDO(1',2':4,5)PYRAZINO(2,1-B)(1,3)OXAZINE-9-CARBOXAMIDE, N-((2,4-DIFLUOROPHENYL)METHYL)-3,4,6,8,12,12A-HEXAHYDRO-7-HYDROXY-4-METHYL-6,8-DIOXO-, SODIUM SALT (1:1), (4R,12AS)-|sodium (4R,12aS)-9-[(2,4-difluorobenzyl)carbamoyl]-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazin-7-olate|Tivicay|Dolutegravir sodium (JAN/USAN)|GSK1349572 sodium|sodium (4R,12aS)-9-((2,4-difluorobenzyl)carbamoyl)-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyrido(1',2':4,5)pyrazino(2,1-b)(1,3)oxazin-7-olate|GSK1349572 sodiuM salt|DOLUTEGRAVIR SODIUM [WHO-DD]|GSK 1349572A|JULUCA COMPONENT DOLUTEGRAVIR SODIUM|Dolutegravir Sodium ( API)|Monosodium (4R,12aS)-9-(((2,4-difluorophenyl)methyl)carbamoyl)-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyrido(1',2':4,5)pyrazino(2,1-b)(1,3)oxazin-7-olate|TRIUMEQ COMPONENT DOLUTEGRAVIR SODIUM|2H-Pyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxamide, N-[(2,4-difluorophenyl)methyl]-3,4,6,8,12,12a-hexahydro-7-hydroxy-4-methyl-6,8-dioxo-, sodium salt (1:1), (4R,12aS)-; Dolutegravir sodium; Dolutegravir sodium salt; GSK 1349572A; GSK 1349572A|TIPT
Storage
Store at -20°C
Shipped In
Ice chest + Ice pads
★
Größe
Deutschland (EU)
USA*
Preis
Menge
5mg
D275163-5mg
—
1 Auf Lager

8,59€

12,93€
Speichern 4,34 € (33.56%)
25mg
D275163-25mg
—
2 Auf Lager

13,80€

20,74€
Speichern 6,94 € (33.47%)
50mg
D275163-50mg
—
2 Auf Lager

24,21€

36,36€
Speichern 12,15 € (33.41%)
100mg
D275163-100mg
Auf Bestellung · 8–12 Wochen

30,28€

45,90€
Speichern 15,62 € (34.03%)
Enter a quantity for the sizes you want to add.

Übersicht

Integrase inhibitors are a new class of antiretroviral drugs blocking the action of HIV integrase, which catalyses several key steps in the life cycle of the virus and is essential for insertion of the viral genome into the host cell DNA. GSK1349572 is a next-generation HIV integrase (IN) inhibitor.

In vitro: GSK1349572 is a two-metal-binding HIV integrase strand transfer inhibitor whose mechanism of action was established through resistance passage experiments, integrase enzyme assays, mechanistic cellular assays and activity against viral strains resistant to other classes of anti-HIV agents. In a variety of cellular antiviral assays, GSK1349572 inhibited HIV replication with subnanomolar or low-nanomolar potency and with a selectivity index of 9,400. The protein-adjusted half-maximal effective concentration extrapolated to 100% human serum was 38 nM .

In vivo: No animial in vivo data are available for GSK1349572 so far.

Clinical trial: GSK1349572 was effective when given once daily without a pharmacokinetic booster and was well tolerated at all assessed doses. These findings support the assessment of once daily 50 mg GSK1349572 in phase 3 trials.

Spezifikationen

Synonyme
DOLUTEGRAVIR SODIUM SALT [MI] | Dolutegravir (sodium) | Dolutegravir sodium salt | Dolutegravir sodium [USAN] | TIVICAY PD | Tivicay (TN) | SODIUM (4R,12AS)-9-(((2,4-DIFLUOROPHENYL)METHYL)CARBAMOYL)-4-METHYL-6,8-DIOXO-3,4,6,8,12,12A-HEXAHYDRO-2H-PYRIDO(1',2':4,5)PYRAZINO(2,1-B)(1,3)OXAZIN-7-OLATE | Sodium (4R,12aS)-9-((2,4-difluorobenzyl) Show more
Spezifikationen & Reinheit
≥99%
Biochemische und physiologische Mechanismen
Dolutegravir Sodium is an HIV-1 integrase inhibitor with an IC 50 of 2.7nM. No effect on total viral DNA synthesis in infected cells but blocks the integration of viral DNA into host DNA.
Storage
Store at -20°C
Verschickt in
Ice chest + Ice pads
Dieses Produkt erfordert Kühlkettenversand. Grundversand und andere Economy-Optionen sind nicht verfügbar.
Aktionsart
INHIBITOR
Mechanismus der Wirkung
Human immunodeficiency virus type 1 integrase inhibitor
Reinheit
≥99%
Namen und Kennungen
Pubchem Sid
Pubchem Sid Url
https://pubchem.ncbi.nlm.nih.gov/substance/504770687
SMILES
CC1CCOC2N1C(=O)C3=C(C(=O)C(=CN3C2)C(=O)NCC4=C(C=C(C=C4)F)F)[O-].[Na+]
IUPAC Name
sodium;(3S,7R)-13-[(2,4-difluorophenyl)methylcarbamoyl]-7-methyl-9,12-dioxo-4-oxa-1,8-diazatricyclo[8.4.0.03,8]tetradeca-10,13-dien-11-olate
InChIKey
UGWJRRXTMKRYNK-VSLILLSYSA-M
InChI
1S/C20H19F2N3O5.Na/c1-10-4-5-30-15-9-24-8-13(17(26)18(27)16(24)20(29)25(10)15)19(28)23-7-11-2-3-12(21)6-14(11)22;/h2-3,6,8,10,15,27H,4-5,7,9H2,1H3,(H,23,28);/q;+1/p-1/t10-,15+;/m1./s1
Isomere SMILES
C[C@@H]1CCO[C@@H]2N1C(=O)C3=C(C(=O)C(=CN3C2)C(=O)NCC4=C(C=C(C=C4)F)F)[O-].[Na+]
Molekulargewicht
441.36
Reaxy-Rn
45353610
Reaxys-RN_link_address
https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN=45353610&ln=

Erweiterte Daten

Taxonomic Classification

Taxonomy Tree

KingdomOrganic compounds
SuperclassOrganoheterocyclic compounds
KlassePyridines and derivatives
SubclassPyridinecarboxylic acids and derivatives
Intermediate Tree Nodes Not available
Direct ParentPyridinecarboxylic acids and derivatives
Alternative Parents 2-heteroaryl carboxamides  Pyridinolates  Fluorobenzenes  1,3-oxazinanes  Aryl fluorides  Vinylogous amides  Vinylogous acids  Tertiary carboxylic acid amides  Heteroaromatic compounds  Secondary carboxylic acid amides  Cyclic ketones  Lactams  Oxacyclic compounds  Azacyclic compounds  Organic metal halides  Organic sodium salts  Organic zwitterions  Organofluorides  Organopnictogen compounds  Hydrocarbon derivatives  Organic oxides  Organonitrogen compounds  
Molecular FrameworkAromatic heteropolycyclic compounds
Substituents Pyridine carboxylic acid or derivatives - 2-heteroaryl carboxamide - Pyridinolate - Fluorobenzene - Halobenzene - 1,3-oxazinane - Aryl fluoride - Aryl halide - Monocyclic benzene moiety - Oxazinane - Benzenoid - Heteroaromatic compound - Tertiary carboxylic acid amide - Vinylogous amide - Vinylogous acid - Carboxamide group - Lactam - Secondary carboxylic acid amide - Cyclic ketone - Organic alkali metal salt - Organic metal halide - Azacycle - Oxacycle - Carboxylic acid derivative - Organic salt - Organonitrogen compound - Organofluoride - Organohalogen compound - Hydrocarbon derivative - Organic oxide - Organooxygen compound - Organic nitrogen compound - Organic oxygen compound - Organopnictogen compound - Organic zwitterion - Organic sodium salt - Aromatic heteropolycyclic compound
BeschreibungThis compound belongs to the class of organic compounds known as pyridinecarboxylic acids and derivatives. These are compounds containing a pyridine ring bearing a carboxylic acid group or a derivative thereof.
External Descriptors organic sodium salt
3D-Struktur
Interaktives chemisches Strukturmodell





Zugehörige Ziele (menschlich)
CYP3A4 Tclin Cytochrome P450 3A4 (53859 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Homo sapiens (32628 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MOLT-4 (49676 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MT4 (17854 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
U-937 (7138 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PBMC (10003 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Zugehörige Ziele (nicht menschlich)
pol Human immunodeficiency virus type 1 integrase (9041 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Canis familiaris (36305 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Rattus norvegicus (775804 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Human immunodeficiency virus 1 (70413 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Human immunodeficiency virus 2 (5592 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MDCK (10148 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Cynomolgus monkey (4946 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Wirkungsmechanismen
Zertifikate (CoA, COO, BSE/TSE und Analyse-Diagramm)
C of A & Other Certificates(BSE/TSE, COO):
Analytical Chart:

Find and download the COA for your product by matching the lot number on the packaging.

5 results found

Lot NumberCertificate TypeDatumArtikel
L2205192L2205192Certificate of AnalysisSep 07, 2026 D275163
L2205190L2205190Certificate of AnalysisSep 07, 2026 D275163
L2205191L2205191Certificate of AnalysisSep 07, 2026 D275163
F2523368F2523368Certificate of AnalysisJun 25, 2025 D275163
L2205196L2205196Certificate of AnalysisOct 14, 2022 D275163
Chemische und physikalische Eigenschaften
Löslichkeit0.2mg/ml in DMSO.
EmpfindlichkeitMoisture sensitive
Molekulargewicht441.400 g/mol
XLogP3
Hydrogen Bond Donor Count1
Hydrogen Bond Acceptor Count8
Rotatable Bond Count3
Exact Mass441.111 Da
Monoisotopic Mass441.111 Da
Topological Polar Surface Area102.000 Ų
Heavy Atom Count31
Formal Charge0
Complexity836.000
Isotope Atom Count0
Defined Atom Stereocenter Count2
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
The total count of all stereochemical bonds0
Covalently-Bonded Unit Count2
Lösungsrechner
Bewertungen

Kundenbewertungen

Dürfen wir Sie über Rabattaktionen informieren?

Später erinnern

Vielen Dank! Bitte überprüfen Sie Ihren E-Mail-Posteingang, um zu bestätigen.

Hoppla! Benachrichtigungen sind deaktiviert.